TYSABRI
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
64406-008 -
Package NDC
64406-008-01 -
Application number
BLA125104 -
SPL ID
f9d13db7-cf1c-44b8-85fa-54d58261fe53 -
SPL set ID
c5fdde91-1989-4dd2-9129-4f3323ea2962 -
UNII
3JB47N2Q2P -
RxCUI
477484 -
RxCUI
603541
What the source publishes
- Labeler
- Biogen Inc.
- Active ingredients
- natalizumab
- Form
- INJECTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "TYSABRI",
"splId": "f9d13db7-cf1c-44b8-85fa-54d58261fe53",
"labels": [
{
"setId": "c5fdde91-1989-4dd2-9129-4f3323ea2962",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5fdde91-1989-4dd2-9129-4f3323ea2962",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5fdde91-1989-4dd2-9129-4f3323ea2962"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Biogen Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-USE in 1 CARTON (64406-008-01) / 15 mL in 1 VIAL, SINGLE-USE",
"package_ndc": "64406-008-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20041123"
}
],
"productId": "64406-008_f9d13db7-cf1c-44b8-85fa-54d58261fe53",
"useDomain": "unknown",
"dosageForm": "INJECTION",
"productNdc": "64406-008",
"deaSchedule": null,
"genericName": "natalizumab",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "NATALIZUMAB",
"strength": "300 mg/15mL"
}
],
"applicationNumber": "BLA125104",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20041123",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175775",
"N0000175774"
],
"unii": [
"3JB47N2Q2P"
],
"rxcui": [
"477484",
"603541"
],
"spl_set_id": [
"c5fdde91-1989-4dd2-9129-4f3323ea2962"
],
"pharm_class_epc": [
"Integrin Receptor Antagonist [EPC]"
],
"pharm_class_moa": [
"Integrin Receptor Antagonists [MoA]"
],
"manufacturer_name": [
"Biogen Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:64406-008_f9d13db7-cf1c-44b8-85fa-54d58261fe53"